C Ohrt

Summary

Publications

  1. ncbi request reprint Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
  2. ncbi request reprint Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong
    W R Taylor
    The British Red Cross Society, Hong Kong
    Int J Tuberc Lung Dis 4:350-5. 2000
  3. ncbi request reprint Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia
    W R Taylor
    United States Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Am J Trop Med Hyg 64:223-8. 2001

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
    ..Corresponding figures for doxycycline were 96.3% (95% CI, 85.4-99.6) and 98% (95% CI, 88.0-99.9), respectively. Daily azithromycin offered excellent protection against P. vivax malaria but modest protection against P. falciparum malaria...
  2. ncbi request reprint Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong
    W R Taylor
    The British Red Cross Society, Hong Kong
    Int J Tuberc Lung Dis 4:350-5. 2000
    ..Two closed camps in Hong Kong for Vietnamese refugees...
  3. ncbi request reprint Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia
    W R Taylor
    United States Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Am J Trop Med Hyg 64:223-8. 2001
    ..vivax. These findings support the use of chloroquine/doxycycline as an inexpensive alternative to mefloquine for treating chloroquine-resistant P. falciparum but not chloroquine-resistant P. vivax in this setting...